CVS Caremark is reversing course on Eli Lilly's weight loss drugs, adding both its shot and new pill to coverage
Cris Tolomia
·
2026-05-28
·
via Quartz
The pharmacy benefit manager dropped Zepbound a year ago in favor of rival Wegovy — now both Lilly and Novo N…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。